molecules of the month

compound 21

oral serine beta-lactamase inh. prodrug

efficacy in murine urinary tract infect. model

from SAR of prior scaffold

Journal of Medicinal Chemistry

Shionogi, Toyonaka, JP

1 min read

12. The Shionogi beta-lactamase inhibitor (BLI) cyclohexyl ester prodrug, compound 21, is a molecule with an interesting sulfinylamide motif on a strained bridgehead nitrogen amide core. The authors used an interesting radical decarboxylative thiolation to introduce the sulfinyl group. This potent oral BLI restores the antibacterial activity of 3rd-gen. cephalosporin, ceftibuten (CTB) against serine beta-lactamase-producing strains including carbapenem-resistant Enterobacteriaceae (CRE). The molecule is efficacious in a murine urinary tract infection model in combination with CTB, and demonstrated safety in a rat 2 week toxicology study. A related molecule, ETX0282, was covered in Jul. 2020.

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: